United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $773,721,457.77
- Nov. 11, 2024
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 26, 2015 | CEO | 2,592 | $182.64 | Sell | $473,402.88 | |
May 21, 2015 | Director | 1,500 | $182.04 | Sell | $273,060.00 | |
May 21, 2015 | CEO | 9,662 | $182.44 | Sell | $1,762,735.28 | |
May 20, 2015 | CEO | 2,211 | $182.80 | Sell | $404,170.80 | |
May 18, 2015 | CEO | 2,592 | $177.79 | Sell | $460,831.68 | |
May 14, 2015 | CEO | 9,662 | $174.07 | Sell | $1,681,864.34 | |
May 13, 2015 | CEO | 2,211 | $175.41 | Sell | $387,831.51 | |
May 11, 2015 | CEO | 2,592 | $179.55 | Sell | $465,393.60 | |
May 7, 2015 | CEO | 9,662 | $169.86 | Sell | $1,641,187.32 | |
May 7, 2015 | Director | 1,500 | $167.94 | Sell | $251,910.00 | |
May 6, 2015 | CEO | 2,211 | $169.22 | Sell | $374,145.42 | |
May 4, 2015 | CEO | 2,592 | $169.81 | Sell | $440,147.52 | |
May 1, 2015 | Director | 3,000 | $159.58 | Sell | $478,740.00 | |
April 30, 2015 | CEO | 9,662 | $162.36 | Sell | $1,568,722.32 | |
April 29, 2015 | CEO | 2,211 | $164.29 | Sell | $363,245.19 | |
April 28, 2015 | CEO | 5,000 | $163.31 | Sell | $816,550.00 | |
April 27, 2015 | CEO | 2,592 | $177.62 | Sell | $460,391.04 | |
April 23, 2015 | CEO | 9,662 | $187.35 | Sell | $1,810,175.70 | |
April 22, 2015 | CEO | 2,211 | $187.49 | Sell | $414,540.39 | |
April 21, 2015 | CEO | 10,000 | $187.86 | Sell | $1,878,600.00 | |
April 20, 2015 | CEO | 2,592 | $184.86 | Sell | $479,157.12 | |
April 16, 2015 | CEO | 11,873 | $187.01 | Sell | $2,220,369.73 | |
April 16, 2015 | EVP | 6,000 | $187.91 | Sell | $1,127,460.00 | |
April 14, 2015 | CEO | 10,000 | $185.82 | Sell | $1,858,200.00 | |
April 14, 2015 | COO | 3,250 | $185.82 | Sell | $603,915.00 | |
April 13, 2015 | CEO | 2,592 | $187.86 | Sell | $486,933.12 | |
April 9, 2015 | COO | 4,000 | $184.84 | Sell | $739,360.00 | |
April 9, 2015 | CEO | 9,662 | $183.09 | Sell | $1,769,015.58 | |
April 8, 2015 | CEO | 2,211 | $181.91 | Sell | $402,203.01 | |
April 7, 2015 | CEO | 10,000 | $179.34 | Sell | $1,793,400.00 | |
April 7, 2015 | COO | 4,000 | $179.34 | Sell | $717,360.00 | |
April 6, 2015 | CEO | 2,592 | $176.20 | Sell | $456,710.40 | |
April 2, 2015 | EVP | 6,000 | $174.73 | Sell | $1,048,380.00 | |
April 2, 2015 | COO | 4,000 | $174.73 | Sell | $698,920.00 | |
April 2, 2015 | Director | 3,000 | $175.49 | Sell | $526,470.00 | |
April 2, 2015 | CEO | 11,873 | $173.43 | Sell | $2,059,134.39 | |
March 30, 2015 | CEO | 2,592 | $177.22 | Sell | $459,354.24 | |
March 26, 2015 | COO | 4,000 | $167.52 | Sell | $670,080.00 | |
March 26, 2015 | CEO | 9,662 | $167.03 | Sell | $1,613,843.86 | |
March 25, 2015 | CEO | 2,211 | $173.67 | Sell | $383,984.37 | |
March 24, 2015 | COO | 4,500 | $179.51 | Sell | $807,795.00 | |
March 23, 2015 | CEO | 2,592 | $177.76 | Sell | $460,753.92 | |
March 19, 2015 | EVP | 6,000 | $175.82 | Sell | $1,054,920.00 | |
March 18, 2015 | CEO | 2,211 | $174.64 | Sell | $386,129.04 | |
March 17, 2015 | COO | 4,000 | $177.34 | Sell | $709,360.00 | |
March 16, 2015 | CEO | 2,592 | $170.97 | Sell | $443,154.24 | |
March 12, 2015 | CEO | 11,873 | $162.94 | Sell | $1,934,586.62 | |
March 10, 2015 | CEO | 18,750 | $143.68 | Sell | $2,694,000.00 | |
March 9, 2015 | CEO | 2,592 | $160.51 | Sell | $416,041.92 | |
March 5, 2015 | Director | 3,000 | $157.59 | Sell | $472,770.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Nov. 11, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.